Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

Surinder Gulati  LinkedIn

Executive Vice President,
India API and Operations

Surinder Gulati is the Executive Vice President of Manufacturing at Piramal Pharma Solutions (PPS). He is responsible for manufacturing and R&D operations for India API sites including Discovery Services along with Global Operational Excellence.

Before his current assignment at PPS, Mr. Gulati played a vital role in setting up the foundation for Piramal Critical Care (PCC) and growing the business. Prior to joining Piramal, Mr. Gulati worked with Matrix Labs, (now Viatris), and Watson (now Teva) in process engineering and capital projects.

Mr. Gulati has close to three decades of experience in API and the pharmaceuticals industry involving plant operations, manufacturing, process engineering, projects, and operational excellence. He led the establishment of several green and brownfield projects globally and was involved in revamping and upgrading facilities across geographies to meet global quality and regulatory requirements at Piramal Pharma.

He is a graduate in Chemical Engineering from Pune University.

Leadership Team

Peter DeYoung    LinkedIn

CEO, Piramal Global Pharma

Stuart Needleman    LinkedIn

Chief Commercial Officer &
Chief Patient Centricity Officer

Herve Berdou    LinkedIn

Chief Operating Officer

Debashish Chakravorty    LinkedIn

Executive Vice President, India Formulations

Manoj Zalpuri    LinkedIn

Executive Vice President, North America Operations

Rashida Najmi    LinkedIn

Chief Quality Officer

Christopher Leahy    LinkedIn

Senior Vice President,